ArticlePharmaceutics2026

Study on Synergistic Treatment of Pancreatic Cancer by Multiple Small Interfering Ribonucleic Acid Lipid Nanoparticles of Disk Domain Receptor 1, Transforming Growth Factor β1, Tumor-Associated Calcium Signal Transduction Protein 2, and Polyligand Proteoglycan 1.

Rongrong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.